scispace - formally typeset
Open AccessJournal ArticleDOI

Rationally Engineered Cas9 Nucleases With Improved Specificity

Reads0
Chats0
TLDR
In this paper, the authors used structure-guided protein engineering to improve the specificity of Streptococcus pyogenes Cas9 (SpCas9) using targeted deep sequencing and unbiased whole-genome off-target analysis to assess Cas9-mediated DNA cleavage in human cells.
Abstract
The RNA-guided endonuclease Cas9 is a versatile genome-editing tool with a broad range of applications from therapeutics to functional annotation of genes. Cas9 creates double-strand breaks (DSBs) at targeted genomic loci complementary to a short RNA guide. However, Cas9 can cleave off-target sites that are not fully complementary to the guide, which poses a major challenge for genome editing. Here, we use structure-guided protein engineering to improve the specificity of Streptococcus pyogenes Cas9 (SpCas9). Using targeted deep sequencing and unbiased whole-genome off-target analysis to assess Cas9-mediated DNA cleavage in human cells, we demonstrate that "enhanced specificity" SpCas9 (eSpCas9) variants reduce off-target effects and maintain robust on-target cleavage. Thus, eSpCas9 could be broadly useful for genome-editing applications requiring a high level of specificity.

read more

Citations
More filters
Journal ArticleDOI

Enhanced CRISPR-based DNA demethylation by Casilio-ME-mediated RNA-guided coupling of methylcytosine oxidation and DNA repair pathways

TL;DR: A toolbox for editing DNA methylation to enable research investigations interrogating DNA methylomes is established and a stable and expression-inducible system for broader application of the Casilio-ME platforms is expanded.
Journal ArticleDOI

CRISPR/Cas9-loxP-Mediated Gene Editing as a Novel Site-Specific Genetic Manipulation Tool

TL;DR: This work successfully generated a CRISPR/Cas9-loxP system to perform gene editing in human cells, providing the proof of principle that these two technologies can be used together for the first time.
Book ChapterDOI

CRISPR/Cas9 for Sickle Cell Disease: Applications, Future Possibilities, and Challenges.

TL;DR: Growth-based approaches to correct the underlying mutation in patient-derived hematopoietic stem/progenitor cells, induce fetal hemoglobin expression to circumvent sickling of red blood cells, or create corrected induced pluripotent stem cells (iPSCs) among other approaches are summarized.
Journal ArticleDOI

Rare Opportunities: CRISPR/Cas-Based Therapy Development for Rare Genetic Diseases

TL;DR: The most significant recent achievements and remaining hurdles in the application of CRISPR/Cas technology to rare diseases are summarized and a glimpse is taken at the exciting road ahead.
References
More filters
Journal ArticleDOI

Geneious Basic

TL;DR: Geneious Basic has been designed to be an easy-to-use and flexible desktop software application framework for the organization and analysis of biological data, with a focus on molecular sequences and related data types.
Journal ArticleDOI

Multiplex Genome Engineering Using CRISPR/Cas Systems

TL;DR: The type II prokaryotic CRISPR (clustered regularly interspaced short palindromic repeats)/Cas adaptive immune system has been shown to facilitate RNA-guided site-specific DNA cleavage as discussed by the authors.

Multiplex Genome Engineering Using CRISPR/Cas Systems

TL;DR: Two different type II CRISPR/Cas systems are engineered and it is demonstrated that Cas9 nucleases can be directed by short RNAs to induce precise cleavage at endogenous genomic loci in human and mouse cells, demonstrating easy programmability and wide applicability of the RNA-guided nuclease technology.
Journal ArticleDOI

RNA-Guided Human Genome Engineering via Cas9

TL;DR: The type II bacterial CRISPR system is engineer to function with custom guide RNA (gRNA) in human cells to establish an RNA-guided editing tool for facile, robust, and multiplexable human genome engineering.
Related Papers (5)